Synapse

← RSC Pharmaceutics

Papers in RSC Pharmaceutics

Page 3 · newest first

  1. Eutectic Formulations in Pharmaceutical Development: A Comprehensive Review of Modulation StrategiesRSC Pharmaceutics · 2025
  2. Brain delivery of biotherapeutics via receptor-mediated transcytosis across the blood-brain barrierRSC Pharmaceutics · 2025
  3. Effective targeting of pathogenic Acanthamoeba castellanii of the T4 genotype using nano-formulations of QuercetinRSC Pharmaceutics · 2025
  4. Aluminium-Complexed Alginate Nanoparticles as an Adjuvant for Therapeutic Vaccine against MelanomaRSC Pharmaceutics · 2025
  5. Novel zwitterionic densely charged neutral sulfobetaine polymeric micelles for oral delivery of therapeutic peptides: a proof-of-concept studyRSC Pharmaceutics · 2025
  6. Brain-targeted intranasal delivery of biologics: a perspective for Alzheimer’s disease treatmentRSC Pharmaceutics · 2025
  7. Lactoferrin-conjugated quercetin-loaded organically modified silica nanocargoes ameliorate cognitive impairment in a rat model of amnesiaRSC Pharmaceutics · 2025
  8. Emerging Smart Microneedle Technologies in Psoriasis: Convergence of Nanocarriers, Machine learning, and Personalized DeliveryRSC Pharmaceutics · 2025
  9. Chitosan-based nano-objects for drug delivery: a review of their chemical modifications, supramolecular organization and biological fateRSC Pharmaceutics · 2025
  10. Redefining LNP Composition: Phospholipid and Sterol-Driven Modulation of mRNA Expression and Immune OutcomesRSC Pharmaceutics · 2025
  11. Emerging drug delivery strategies for glaucoma therapy: Focus on nanoparticles and stimuli responsive systemsRSC Pharmaceutics · 2025
  12. Mitigating oxidative stress in red blood cells with quercetin-loaded liposomes: a promising strategyRSC Pharmaceutics · 2025
  13. Intratumor microbiota: a new perspective in cancer initiation, development, and therapyRSC Pharmaceutics · 2025
  14. Reversibility of FUS-aided blood-tumor barrier opening for the delivery of therapeutics.RSC Pharmaceutics · 2025
  15. Clobetasol Propionate and Pramoxine Hydrochloride Loaded Nanolipid Carrier Gel for the Treatment of Atopic DermatitisRSC Pharmaceutics · 2025
  16. The potential of small extracellular vesicles for pancreatic cancer therapyRSC Pharmaceutics · 2025
  17. Unlocking the potential of exosomes ‘extracellular vesicles’: drug delivery advancements and therapeutics in ocular diseasesRSC Pharmaceutics · 2025
  18. Biopolymeric films based on chitosan and copaiba oleoresin: preliminary insights for oral applicationsRSC Pharmaceutics · 2025
  19. Development and Evaluation of N-acetyl cysteine‑grafted Polyamidoamine Dendrimers for Enhanced Brain Delivery of Donepezil hydrochlorideRSC Pharmaceutics · 2025
  20. Release performance and crystallization of racemic and enantiopure praziquantel amorphous solid dispersion in various mediaRSC Pharmaceutics · 2025
  21. Ion pairing as a strategy to enhance the delivery of diclofenacRSC Pharmaceutics · 2025
  22. Preliminary Evidence for the Combined Efficacy of Focused Ultrasound Blood-Brain Barrier Opening and Re-1 Delivery for Anxiety and Memory Improvement in a 3xTg-Alzheimer’s Dis-ease Mouse ModelRSC Pharmaceutics · 2025
  23. Recent advances in biomedical applications of smart nanomaterials: A comprehensive reviewRSC Pharmaceutics · 2025
  24. Drug release from binary and ternary flexible dose combinations manufactured by drop-on-demand impregnation of mesoporous silica tabletsRSC Pharmaceutics · 2025
  25. Exploring hot melt extrusion in the formation of exemestane / amino acids co-amorphous systemsRSC Pharmaceutics · 2025
  26. Cyclodextrin-Based Nanosponge Co-Delivery of Doxorubicin and EMD: Synergistic Anticancer Activity with Improved Selectivity Toward Cancer CellsRSC Pharmaceutics · 2025
  27. Breaking the cellular delivery bottleneck: recent developments in direct cytosolic delivery of biologicsRSC Pharmaceutics · 2025
  28. Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approachesRSC Pharmaceutics · 2025
  29. Introduction, classification and applications of 3D bioprinted hydrogels for cancer treatment: a reviewRSC Pharmaceutics · 2025
  30. Controlled isolation of a novel polymorphic form of chlorothiazide by spray dryingRSC Pharmaceutics · 2025
  31. Glivec to generic imatinib switch: in vitro comparative dissolution assessment, bioequivalence, safety, and tolerability of 400 mg imatinib tablets in healthy volunteersRSC Pharmaceutics · 2025
  32. Redox-responsive micellar-like nanoparticles can overcome intrinsic multi-drug resistance in tumour spheroids of triple negative breast cancerRSC Pharmaceutics · 2025
  33. Nanosensors in healthcare: transforming real-time monitoring and disease management with cutting-edge nanotechnologyRSC Pharmaceutics · 2025
  34. Advances in targeted therapies and emerging strategies for blood cancer treatmentRSC Pharmaceutics · 2025
  35. Vaccine formulation design: challenges and opportunitiesRSC Pharmaceutics · 2025
  36. Phenylboronic acid derivatives: advancing glucose-responsive insulin delivery and multifunctional biomedical applicationsRSC Pharmaceutics · 2025
  37. 3D printing of tailored veterinary dual-release tablets: a semi-solid extrusion approach for metoclopramideRSC Pharmaceutics · 2025
  38. Comparison of polymer-coated, drug-eluting self-expandable metal stents for the potential treatment of gastrointestinal cancersRSC Pharmaceutics · 2025
  39. Polybasic nanogels for intracellular co-delivery of paclitaxel and carboplatin: a novel approach to ovarian cancer therapyRSC Pharmaceutics · 2025
  40. Tailoring bromelain-loaded lipid–polymer hybrid nanoparticles for asthma management: fabrication and preclinical evaluationRSC Pharmaceutics · 2025
  41. Influence of Spinacia oleracea leaf extract concentration on silver nanoparticle formation and evaluation of antimicrobial propertiesRSC Pharmaceutics · 2025
  42. Solid lipid nanoparticles in cervical cancer: a comprehensive review of a decade of progress and prospectsRSC Pharmaceutics · 2025
  43. Optimizing mesoporous silica synthesis procedures to enhance their potential as nanoplatforms in therapeutic applicationsRSC Pharmaceutics · 2025
  44. A new strategy for the extrahepatic delivery of lipid-based nanomedicines: a protein corona-mediated selective targeting system based on an ionizable cationic lipid libraryRSC Pharmaceutics · 2025
  45. Artesunate-loaded bilosomes with enhanced oral bioavailability: in silico and in vitro study against Leishmania donovani promastigotes and in vivo pharmacokinetic assessment in ratsRSC Pharmaceutics · 2025
  46. AI-driven innovations in pharmaceuticals: optimizing drug discovery and industry operationsRSC Pharmaceutics · 2025
  47. Development of solid drug nanoparticle dispersions for pulmonary delivery of niclosamide and nitazoxanide via vibrating mesh nebulisationRSC Pharmaceutics · 2025
  48. Personalized medicine: a quality by design approach to printable tablet productionRSC Pharmaceutics · 2025
  49. Biomimetic nanoparticles for targeted therapy of liver diseaseRSC Pharmaceutics · 2025
  50. The rise of mRNA therapeutic vaccinesRSC Pharmaceutics · 2025